Lv3
368 积分 2021-04-08 加入
Rationale, current state and opportunities in combining biologic disease modifying antirheumatic drugs in rheumatoid and psoriatic arthritis
7天前
已完结
The pipeline and market for psoriasis drugs
14天前
已完结
Risankizumab for Ulcerative Colitis
20天前
已完结
Risankizumab for Ulcerative Colitis
20天前
已完结
Cytokines of the IL‐17 family in psoriasis
2个月前
已完结
骨关节炎诊疗指南（2018年版）
3个月前
已完结
[Recommendations of diagnosis and treatment of primary Sjögren's syndrome in China]
3个月前
已完结
Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis
3个月前
已完结
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
5个月前
已完结
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
5个月前
已完结
皖公网安备34019202002308
